Audevard Labs acquires Ceva’s equine product range in Europe
|Client||Audevard (European pharmaceutical laboratory exclusively dedicated to equine health)|
|Sector||Healthcare – Animal Health|
|Deal||Audevard secures Ceva’s equine product range in Europe.|
What we did:
- Capitalmind actively supported the Audevard team and its shareholders all along the acquisition process: from first talks with Ceva senior management to preliminary negotiations, valuation and structuring guidance, execution support up to closing, and assistance in the negotiation of the final legal documentation.